Date Time | Announcment |
|---|---|
| Oct 06, 2026, 8:51 PM IST | Alembic Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 18, 2026, 10:59 PM IST | Alembic Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 16, 2026, 11:37 PM IST | Alembic Pharma. - Update On USFDA Inspection Conducted During 3Rd March, 2025 To 7Th March, 2025 At Bioequivalence Facility L |
| Sep 11, 2026, 5:08 PM IST | Alembic Pharma. - Intimation Regarding Successful Completion Of Unannounced USFDA Onsite Bioequivalence Inspection. |
| Sep 08, 2026, 2:04 AM IST | Alembic Pharma. - Intimation Under Regulation 30 Of SEBI LODR Regulations, 2015 - Incorporation Of A Wholly Owned Subsidiary |
| Aug 27, 2026, 9:59 PM IST | Alembic Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Aug 27, 2026, 9:57 PM IST | Alembic Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Aug 21, 2026, 12:32 AM IST | Alembic Pharma. - Appointment of Company Secretary and Compliance Officer |
| Aug 11, 2026, 12:31 AM IST | Alembic Pharma. - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer |
| Aug 10, 2026, 6:24 AM IST | Alembic Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |